Free calculator · No signup
Build vs Buy — Pharmaceuticals
Weigh SaaS subscriptions against a custom build for Pharmaceuticals — see the multi-year total cost of ownership and which path wins.
What this means for Pharmaceuticals
- Clinical trial recruitment runs 30-50% behind plan; site activation takes 8-12 months and patient screening is manual chart review.
- Regulatory submissions (NDA, BLA, MAA) are coordinated across dozens of CROs, sites, and writers via SharePoint and version-numbered Word documents.
- Pharmacovigilance case intake is drowning in adverse-event reports; medical reviewers spend nights triaging individual case safety reports.
Where it pays to act
- Trial recruitment acceleration — AI screening of EMR and claims data to identify eligible patients.
- Regulatory submission drafting and consistency checking with LLM-assisted authoring.
Adjust the inputs to match your Pharmaceuticals context.
Total cost of ownership
SaaS total (3yr)
₹19.9 L
Custom build total
₹21.8 L
Difference (cheaper to buy)
₹1.89 L
Breakeven
—
What this means
A hybrid path fits best.
For Pharmaceuticals, the gap is ₹1.89 L over 3 years — close enough that a hybrid approach (buy core, build differentiating layers) often wins.
Project inquiry
Tell us about your project.
No sign-up, and nothing is stored. Submitting opens your email or WhatsApp with the details pre-filled and ready to send.
Build vs buy — summary
More tools for Pharmaceuticals
AI Readiness Audit
Score process clarity, data readiness, team adoption, and guardrails before investing in AI.
Sample output
67/100 → pilot with control, not full rollout
Digital Transformation Audit
Assess KPI clarity, reporting, tool alignment, ownership, and automation maturity.
Sample output
52/100 → foundation gaps in metrics and handoffs
Cost of Manual Work — Pharmaceuticals
Quantify the annual cost and people-weeks lost to repetitive manual work — and the automation payback.
Revenue Leak — Pharmaceuticals
See how much revenue leaks every month from a low conversion rate — and what closing the gap to your target is worth.
AI Readiness Audit — Pharmaceuticals
Score whether your team has the strategy, data, process, and guardrails to deploy practical AI — framed around the highest-ROI use cases for your sector.
Operations Maturity Audit — Pharmaceuticals
Score how mature your operations are across metrics, handoffs, tooling, ownership, and automation — and pinpoint the weakest link to fix first.